Showing results (5001-5010 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 2, 2018
Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE-Mutant Uterine CarcinosarcomaMunveer S Bhangoo, Peter Boasberg, Pareen Mehta, et al.The Oncologist|January 11, 2018
Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following ApprovalSean Khozin, Amy P Abernethy, Nathan C Nussbaum, et al.The Oncologist|December 7, 2018
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer TherapyDaniel S O'Neil, Sarah Nietz, Ines Buccimazza, et al.The Oncologist|December 7, 2018
Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic GradeOtto Metzger-Filho, Arlindo R Ferreira, Rinath Jeselsohn, et al.The Oncologist|December 7, 2018
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective StudyGiovanni Fucà, Nadia Hindi, Isabelle Ray-Coquard, et al.The Oncologist|December 14, 2018
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing ChemotherapyDaniel L Suzman, Sundeep Agrawal, Yang-Min Ning, et al.The Oncologist|December 16, 2018
Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I TrialCarl-Henrik Shah, Helle Pappot, Mads Agerbæk, et al.The Oncologist|December 16, 2018
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)Herbert I Hurwitz, Benjamin R Tan, James A Reeves, et al.The Oncologist|December 16, 2018
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast CancerKirsten A Nyrop, Allison M Deal, Shlomit S Shachar, et al.The Oncologist|December 21, 2018
Prevalence of Burnout and Career Satisfaction Among Oncologists in China: A National SurveyShuxiang Ma, Yan Huang, Yunpeng Yang, et al.Pageof 571